AzTrials
AzTrials

the Recommended Target of Daily Vegetables IntakeLPV in CKDNCT06428942

Low-potassium Content Vegetables in Chronic Kidney Disease

A study testing low-potassium vegetables in people with the Recommended Target of Daily Vegetables Intake and Risk of Hyperkalemia, run by Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation at 2 sites in Taiwan.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Prior observational studies have shown that higher levels of vegetables and fruits consumption are associated with lower risk of all-cause mortality in patients with chronic kidney disease (CKD). However, compared with the normal population, patients with CKD are more likely to consume less vegetables and fruits. Read more about this study

Who is it for?
Ages 20 to 99 years
What is being tested?
low-potassium vegetables
Could I receive a placebo?
No, everyone receives an active treatment
How many people
75 participants
Where
2 sitesTaiwan
Study dates
27 May 2024to 31 Dec 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 99 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • CKD stage 3b~5, not yet on dialysis
  • Age ≥20 years
  • Stable doses of medications for 4 weeks
  • Serum potassium level: ≥3.5 and < 5.5 mmol/L

Who cannot join

  • Anticipated to receive dialysis within 3 month
  • Major gastrointestinal diseases (inflammatory bowel disease, celiac disease) or intestinal resection
  • Patients with infection, malignancy, heart failure, liver cirrhosis or impaired cognitive or mental disorders
  • Patients who are just hospitalized due to an acute cardiovascular events or infection 3 months prior to the start of study
  • Patients with kidney transplants
  • Patients who receive immunosuppressant
  • Pregnant women or patients who are planning to become pregnant

Trial locations and contacts

2 sites in 1 country.

Taiwan2 sites, 2 recruiting
  • Taipei Tzu Chi Hospital

    New Taipei City, 231

    Ting-Yun Lin, MD, 8862-6628-9779 ext. 2350, water_h2o_6@hotmail.com

    Szu-chun Hung, MD, 8862-6628-9779 ext. 2350, szuchun.hung@gmail.com

    Recruiting
  • Taipei Tzu Chi Hospital

    New Taipei City

    Szu-Chun Hung, MD

    Recruiting

Other trials in Taiwan

About this study

Official title: Increased Low-potassium Content Vegetables Consumption in Patients With Moderate-to-severe Chronic Kidney Disease: a Randomized Controlled Trial

Prior observational studies have shown that higher levels of vegetables and fruits consumption are associated with lower risk of all-cause mortality in patients with chronic kidney disease (CKD). However, compared with the normal population, patients with CKD are more likely to consume less vegetables and fruits. Thus, the investigators aim to evaluate whether proving low-potassium content vegetables to this population are able to reach the recommended target of daily vegetables intake and not increase the risk of hyperkalemia.

Read the detailed description

Prior observational studies have shown that higher levels of vegetables and fruits consumption are associated with lower risk of all-cause mortality in patients with chronic kidney disease (CKD). However, compared with the normal population, patients with CKD are more likely to consume less vegetables and fruits. According to the suggestions from 2018 Ministry of Health and Welfare in Taiwan, vegetables intake are at least 3 to 5 servings daily based on the daily energy requirement. In our own data, the average daily vegetables intake was only 2.1 servings among patients with CKD stages 3 to 5 not yet on dialysis. Therefore, the investigators aim to evaluate whether proving low-potassium content vegetables to patients with CKD stages 3 to 5 not yet on dialysis are able to reach the recommended target of daily vegetables intake and not increase the risk of hyperkalemia.

Being tested
low-potassium vegetables
Keywords
chronic kidney disease, vegetables, hyperkalemia
Medical subject headings
Renal Insufficiency, Chronic, Hyperkalemia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • low-potassium vegetablesOther

    low-potassium vegetables 3 to 5 serving according to their daily suggested requirement

Study groups in NCT06428942
Study groupRoleWhat they receive
Intervention groupExperimentalThe participants in the intervention group would receive their daily low-potassium vegetables 3 to 5 serving according to their daily suggested requirement and routine CKD dietary education for 8 weeks.
Receives: Other: low-potassium vegetables
Control groupNo interventionThe participants in the control group would receive routine CKD dietary education for 8 weeks.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Percentage of participants who reach the targets of daily vegetable recommended target

    Percentage of participants who reach the targets of daily vegetable recommended

    Measured: 8 weeks

Secondary outcomes (6)
  1. Gut-derived uremic toxins

    Change in gut-derived uremic toxins ( indoxyl sulfate, p-cresyl sulfate)

    Measured: 8 weeks

  2. Serum creatinine

    Change in serum creatinine in mg/dL

    Measured: 8 weeks

  3. Proteinuria

    Change in proteinuria in g/day

    Measured: 8 weeks

  4. Occurrence of moderate hyperkalemia

    serum [potassium] >=5.5 mmol/L

    Measured: 8 weeks

  5. Status of constipation

    Using the Chinese constipation questionnaire. The minimum value is 0, and the maximum value is 21, and the higher score represents a worse outcome.

    Measured: 8 weeks

  6. Gut microbiome

    Change in alpha- and beta-diversities indices

    Measured: 8 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 May 2024
  2. Study start27 May 2024 (estimated)
  3. Primary completion31 Dec 2024 (estimated)
  4. Study completion31 Dec 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Model description
Participants are randomized to intervention group or control group with ratio of 50:25.
Masking
None (open label)
Enrolment
75 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06428942
Sponsor's protocol ID
12-XD-093
Acronym
LPV in CKD
Status last verified
May 2024
First submitted
15 May 2024
Last updated
29 May 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: We do not have IPD sharing plan.

Publications

  • Wakasugi M, Yokoseki A, Wada M, Momotsu T, Sato K, Kawashima H, Nakamura K, Onodera O, Narita I. Vegetable and Fruit Intake Frequency and Mortality in Patients With and Without Chronic Kidney Disease: A Hospital-Based Cohort Study. J Ren Nutr. 2023 Jul;33(4):566-574. doi: 10.1053/j.jrn.2023.01.011. Epub 2023 Feb 13.

    PubMed 36791982
  • Saglimbene VM, Wong G, Ruospo M, Palmer SC, Garcia-Larsen V, Natale P, Teixeira-Pinto A, Campbell KL, Carrero JJ, Stenvinkel P, Gargano L, Murgo AM, Johnson DW, Tonelli M, Gelfman R, Celia E, Ecder T, Bernat AG, Del Castillo D, Timofte D, Torok M, Bednarek-Skublewska A, Dulawa J, Stroumza P, Hoischen S, Hansis M, Fabricius E, Felaco P, Wollheim C, Hegbrant J, Craig JC, Strippoli GFM. Fruit and Vegetable Intake and Mortality in Adults undergoing Maintenance Hemodialysis. Clin J Am Soc Nephrol. 2019 Feb 7;14(2):250-260. doi: 10.2215/CJN.08580718. Epub 2019 Jan 31.

    PubMed 31738182
  • Pourafshar S, Sharma B, Kranz S, Mallawaarachchi I, Kurland E, Ma JZ, Scialla JJ. Patterns of Fruit and Vegetable Intake in Adults With and Without Chronic Kidney Disease in the United States. J Ren Nutr. 2023 Jan;33(1):88-96. doi: 10.1053/j.jrn.2022.06.007. Epub 2022 Jul 5.

    PubMed 35798188

Questions about this trial

What is this clinical trial studying?

A study testing low-potassium vegetables in people with the Recommended Target of Daily Vegetables Intake and Risk of Hyperkalemia, run by Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation at 2 sites in Taiwan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 29 May 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact TIng-Yun Lin, MD (886-266289779 ext. 2350, water_h2o_6@hotmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Percentage of participants who reach the targets of daily vegetable recommended target (time frame: 8 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06428942, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 May 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in